Artificial lung keeps patient alive after lung removal

	Pulmonology
	The latest pulmonology news from News Medical

	Artificial lung keeps patient alive after lung removal Researchers evaluate the effectiveness of a novel extracorporeal total artificial lung system to enable bilateral pneumonectomy in patients with severe ARDS.

	Influenza D virus and canine coronavirus pose human risks Two emerging pathogens with animal origins - influenza D virus and canine coronavirus - have so far been quietly flying under the radar, but researchers warn conditions are ripe for the viruses to spread more widely among humans.

			Burn pit particles trigger lung inflammation through immune activation A new study from National Jewish Health helps explain how exposure to burn pit smoke and desert dust may damage the lungs of military service members deployed to regions such as Afghanistan and Iraq.

			Tirzepatide shows dual benefits in sleep apnea trial improving metabolism and reducing inflammation Tirzepatide significantly improved cardiometabolic risk markers in adults with obesity and moderate to severe obstructive sleep apnea in the SURMOUNT-OSA phase 3 trials. Mediation analyses suggest both weight loss and reduced sleep-disordered breathing contributed to improvements in inflammation, insulin resistance, lipids, and blood pressure.

			Non-invasive FeNO testing for asthma care Learn how FeNO testing supports the assessment of airway inflammation in asthma management.

	Beta arrestin 1 emerges as key driver of pulmonary hypertension Researchers have uncovered the pivotal role of a previously overlooked protein in the development of the serious illness.

	Early tuberculosis treatment reduces sepsis deaths in HIV patients Sepsis is a leading global cause of hospital deaths, occurring when the body's response to infection damages tissue and causes organs to fail. Africa bears the world's highest burden of sepsis, with an estimated 48 million cases each year leading to about 11 million deaths.

	Too many antioxidants may negatively affect future offspring Antioxidants have been marketed as miracle supplements, touted for preventing chronic diseases and cancers; treating COPD and dementia; and slowing aging.

Why did you receive this email?
You are receiving this email because you subscribed to updates from AZoNetwork UK Ltd. on one of our websites and requested to be notified of additional information.

Unsubscribe or Update Notification Preferences

Contact | About | Privacy Policy

- - - - - -

Registered Address:
AZoNetwork UK Ltd.,

Manchester | Sydney | Boston

Copyright © 2000-2026